The Role of Social Media in Healthcare: Why Channel, Content, & Credibility are Key

Published June 30th, 2022 | 3 Minute Read

In 2022, social media – a key element of social health –  is transforming at lightning speed right before our eyes. From sharing information to building community, billions of people take action on social media everyday—and from the perspective of the pharmaceutical industry, harnessing its power has never been more critical. Today, social media usage presents pharma with a unique opportunity to meet patients where they are across a variety of channels, through actions such as scrolling through a timeline, watching a video, or taking a leap of faith and joining an online support group, allowing users to feel more informed and less alone in their health condition.

While the opportunity to reach people where they are on social may be exponential, there are some challenges. Changing consumer behavior paired with evolving technology and privacy restrictions make it seem like reaching patients on social media is near impossible; however, these engaged, action-oriented audiences are seeking information through social, and are reachable with the right channel, content, and credible approach.

Social health drives patient interaction and support on social media platforms

Social health—the dynamic, real-time action people take to find meaningful connections and share information that impact the health journey—is paving the way forward for pharma to spark real change on digital platforms. A recent social health survey* of 2,346 respondents across a variety of conditions suggests that 95% of patients use social resources for health purposes, and these patients are engaging during critical situations that impact health decisions

Separately, 233 socially engaged patients across a variety of health conditions were surveyed** to provide pharma marketers with a guide on the role of social media today in patients’ lives. According to this survey:

  • Of all social media channels, Facebook is the most widely used social media platform for condition-specific support groups and treatment research
  • Patients looking to share their own perspectives and learn about other real-life accounts are most drawn to Instagram over other social platforms

Survey respondents indicate they use social media channels to seek connection, news, and more.

Related Articles

Building Relationships vs. Publishing Content: Reflecting on the Renewed Interest In Migraine Disease

A new class of migraine drugs, called anti-CGRPs (calcitonin gene-related peptide) are expected to reinvigorate a market that has been largely dormant for some time. Four biopharma companies, Amgen, Teva, Lilly and Alder are entering the fray. Not surprisingly, the intense competition and pharma investment associated with this market dynamic has led traditional “eyeball driven” publishers, like WebMD, Everyday Health and others on a quest to offer substantially more migraine-related content in reaction to this market opportunity.

WebMD Sale Reflects Trend towards Smarter Spending in Pharma Advertising

Last month, headline writers had a field day dreaming up puns for coverage about several pharmaceutical companies’ decision not to run ads for erectile dysfunction drugs during this season’s NFL broadcasts. And, while a connection to the recent sale of WebMD might not be immediately obvious, upon closer examination, these stories share a common theme. Both reflect the shifting sands beneath the pharmaceutical industry and how, in reacting to them, its marketers are being challenged to do more with less.

Within the 2021 social health survey* patient leaders across all conditions indicated that users often look to at least one social resource for health-related information or decision-making support. This survey also validated Facebook as the most commonly used social media platform for health purposes, outranking reputable online resources such as patient portals and hospital and health websites.  

By fusing the individual and communal components of patient experiences, Facebook continues to solidify its position as a standout social media network for health-related information. These intricate views of patient culture and activity among varied platforms prove that social media is no longer a “one size fits all” game.

Patients look to social media for personal perspectives, expert insights, and credible answers

While navigating social media may seem like information overload, content that appears while scrolling often makes a lasting impact. The 2021 social media survey** paired with real-world examples from the Psoriatic Arthritis community illustrate this idea quite well:

Patients indicate interest level in various types of pharma content on social media.Credibility is imperative on social platforms

Consumer trust is a critical topic that has taken a front row seat in countless industries as social media networks are used virtually everywhere to spark meaningful conversations and share information. As pharma marketers generate social media content, they may ask if patients trust the content they come across or whether they search for information verification and accuracy. According to the survey**:

  • Approximately 90% of respondents indicated that the verification and accuracy of information in a social media post is somewhat or very important
  • Individual medical professionals, healthcare/hospital systems, online health providers, and online patient community leaders are among the most trustworthy information sources
  • YouTube and Facebook were ranked the most overall trusted social media platforms for health-related information

Graph displays mean trustworthiness overall of several social media platforms.

Combining these key findings leaves pharma marketers with a deeper, more comprehensive understanding of patient thought processes and journeys. Reaching a quality audience on social media requires understanding where patients are connecting through credible content and crafting accurate and valuable social media messaging. 

Along this journey, social health usage converges with social media networks to create mutually beneficial opportunities for key stakeholders in the healthcare industry. Through socially driven solutions designed to fit needs related to content, context, community, and influencer marketing programs, partnering with Health Union can help your brand expertly navigate the social media landscape by plugging you into the power of social health. 

*2021 survey conducted by Health Union, n=2,346

**2021 survey conducted by WEGO Health & the Digital Health Coalition, n=233

Related Articles

Building Relationships vs. Publishing Content: Reflecting on the Renewed Interest In Migraine Disease

A new class of migraine drugs, called anti-CGRPs (calcitonin gene-related peptide) are expected to reinvigorate a market that has been largely dormant for some time. Four biopharma companies, Amgen, Teva, Lilly and Alder are entering the fray. Not surprisingly, the intense competition and pharma investment associated with this market dynamic has led traditional “eyeball driven” publishers, like WebMD, Everyday Health and others on a quest to offer substantially more migraine-related content in reaction to this market opportunity.

WebMD Sale Reflects Trend towards Smarter Spending in Pharma Advertising

Last month, headline writers had a field day dreaming up puns for coverage about several pharmaceutical companies’ decision not to run ads for erectile dysfunction drugs during this season’s NFL broadcasts. And, while a connection to the recent sale of WebMD might not be immediately obvious, upon closer examination, these stories share a common theme. Both reflect the shifting sands beneath the pharmaceutical industry and how, in reacting to them, its marketers are being challenged to do more with less.